Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference112 articles.
1. Cellular signaling by fibroblast growth factor receptors;Eswarakumar;Cytokine Growth Factor Rev.,2005
2. Fibroblast growth factor signalling: from development to cancer;Turner;Nat. Rev. Cancer,2010
3. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor;Yayon;Cell,1991
4. Exploring mechanisms of FGF signalling through the lens of structural biology;Goetz;Nat. Rev. Mol. Cell Biol.,2013
5. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer;Sato;Oncol. Rep.,2009
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment;Frontiers in Molecular Biosciences;2024-06-11
2. Discovery and development of quinazoline compounds as irreversible pan-fibroblast growth factor receptor inhibitors with potent antitumor activities;Journal of Molecular Structure;2024-03
3. Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma;Archiv der Pharmazie;2024-01-31
4. FGFR and inhibitors;Fibroblast Growth Factors;2024
5. Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma;Cancers;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3